139 related articles for article (PubMed ID: 37781295)
1. Safety confirmation of induced pluripotent stem cell-derived cardiomyocyte patch transplantation for ischemic cardiomyopathy: first three case reports.
Kawamura T; Ito Y; Ito E; Takeda M; Mikami T; Taguchi T; Mochizuki-Oda N; Sasai M; Shimamoto T; Nitta Y; Yoshioka D; Kawamura M; Kawamura A; Misumi Y; Sakata Y; Sawa Y; Miyagawa S
Front Cardiovasc Med; 2023; 10():1182209. PubMed ID: 37781295
[TBL] [Abstract][Full Text] [Related]
2. Case report: Transplantation of human induced pluripotent stem cell-derived cardiomyocyte patches for ischemic cardiomyopathy.
Miyagawa S; Kainuma S; Kawamura T; Suzuki K; Ito Y; Iseoka H; Ito E; Takeda M; Sasai M; Mochizuki-Oda N; Shimamoto T; Nitta Y; Dohi H; Watabe T; Sakata Y; Toda K; Sawa Y
Front Cardiovasc Med; 2022; 9():950829. PubMed ID: 36051285
[TBL] [Abstract][Full Text] [Related]
3. Establishment and Industrialization of a New Treatment Method Using Regenerative Cardiomyocyte Transplantation for Refractory Severe Heart Failure - Secondary Publication.
Fukuda K
JMA J; 2023 Oct; 6(4):388-392. PubMed ID: 37941693
[TBL] [Abstract][Full Text] [Related]
4. Establishment of a protocol to administer immunosuppressive drugs for iPS cell-derived cardiomyocyte patch transplantation in a rat myocardial infarction model.
Ito E; Kawamura A; Kawamura T; Takeda M; Harada A; Mochizuki-Oda N; Sawa Y; Miyagawa S
Sci Rep; 2023 Jun; 13(1):10530. PubMed ID: 37385993
[TBL] [Abstract][Full Text] [Related]
5. Cryopreserved Off-the-Shelf Allogeneic Adipose-Derived Stromal Cells for Therapy in Patients with Ischemic Heart Disease and Heart Failure-A Safety Study.
Kastrup J; Haack-Sørensen M; Juhl M; Harary Søndergaard R; Follin B; Drozd Lund L; Mønsted Johansen E; Ali Qayyum A; Bruun Mathiasen A; Jørgensen E; Helqvist S; Jørgen Elberg J; Bruunsgaard H; Ekblond A
Stem Cells Transl Med; 2017 Nov; 6(11):1963-1971. PubMed ID: 28880460
[TBL] [Abstract][Full Text] [Related]
6. Intramyocardial Transplantation of Human iPS Cell-Derived Cardiac Spheroids Improves Cardiac Function in Heart Failure Animals.
Kawaguchi S; Soma Y; Nakajima K; Kanazawa H; Tohyama S; Tabei R; Hirano A; Handa N; Yamada Y; Okuda S; Hishikawa S; Teratani T; Kunita S; Kishino Y; Okada M; Tanosaki S; Someya S; Morita Y; Tani H; Kawai Y; Yamazaki M; Ito A; Shibata R; Murohara T; Tabata Y; Kobayashi E; Shimizu H; Fukuda K; Fujita J
JACC Basic Transl Sci; 2021 Mar; 6(3):239-254. PubMed ID: 33778211
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy of large aligned cardiac tissue derived from induced pluripotent stem cell in a porcine ischemic cardiomyopathy model.
Suzuki K; Miyagawa S; Liu L; Kawamura T; Li J; Qu X; Harada A; Toda K; Yoshioka D; Kainuma S; Kawamura A; Sawa Y
J Heart Lung Transplant; 2021 Aug; 40(8):767-777. PubMed ID: 34108109
[TBL] [Abstract][Full Text] [Related]
8. Clinical Outcomes of Autologous Stem Cell-Patch Implantation for Patients With Heart Failure With Nonischemic Dilated Cardiomyopathy.
Domae K; Miyagawa S; Yoshikawa Y; Fukushima S; Hata H; Saito S; Kainuma S; Kashiyama N; Iseoka H; Ito E; Harada A; Takeda M; Sakata Y; Toda K; Pak K; Yamada T; Sawa Y
J Am Heart Assoc; 2021 Jul; 10(13):e008649. PubMed ID: 34212772
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of clinical-grade human induced pluripotent stem cell-derived cardiac tissues.
Osada H; Kawatou M; Fujita D; Tabata Y; Minatoya K; Yamashita JK; Masumoto H
JTCVS Open; 2021 Dec; 8():359-374. PubMed ID: 36004071
[TBL] [Abstract][Full Text] [Related]
10. Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With ST-Segment Elevation Myocardial Infarction and Left Ventricular Dysfunction.
Fernández-Avilés F; Sanz-Ruiz R; Bogaert J; Casado Plasencia A; Gilaberte I; Belmans A; Fernández-Santos ME; Charron D; Mulet M; Yotti R; Palacios I; Luque M; Sádaba R; San Román JA; Larman M; Sánchez PL; Sanchís J; Jiménez MF; Claus P; Al-Daccak R; Lombardo E; Abad JL; DelaRosa O; Corcóstegui L; Bermejo J; Janssens S
Circ Res; 2018 Aug; 123(5):579-589. PubMed ID: 29921651
[TBL] [Abstract][Full Text] [Related]
11. Danish phase II trial using adipose tissue derived mesenchymal stromal cells for patients with ischaemic heart failure.
Qayyum AA; Mouridsen M; Nilsson B; Gustafsson I; Schou M; Nielsen OW; Hove JD; Mathiasen AB; Jørgensen E; Helqvist S; Joshi FR; Johansen EM; Follin B; Juhl M; Højgaard LD; Haack-Sørensen M; Ekblond A; Kastrup J
ESC Heart Fail; 2023 Apr; 10(2):1170-1183. PubMed ID: 36638837
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
[TBL] [Abstract][Full Text] [Related]
13. MHC-mismatched Allotransplantation of Induced Pluripotent Stem Cell-derived Cardiomyocyte Sheets to Improve Cardiac Function in a Primate Ischemic Cardiomyopathy Model.
Kashiyama N; Miyagawa S; Fukushima S; Kawamura T; Kawamura A; Yoshida S; Eiraku S; Harada A; Matsunaga K; Watabe T; Toda K; Hatazawa J; Sawa Y
Transplantation; 2019 Aug; 103(8):1582-1590. PubMed ID: 31107828
[TBL] [Abstract][Full Text] [Related]
14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
15. Co-transplantation of Mesenchymal Stromal Cells and Induced Pluripotent Stem Cell-Derived Cardiomyocytes Improves Cardiac Function After Myocardial Damage.
Neef K; Drey F; Lepperhof V; Wahlers T; Hescheler J; Choi YH; Šarić T
Front Cardiovasc Med; 2021; 8():794690. PubMed ID: 35071360
[TBL] [Abstract][Full Text] [Related]
16. Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model.
Kawamura M; Miyagawa S; Miki K; Saito A; Fukushima S; Higuchi T; Kawamura T; Kuratani T; Daimon T; Shimizu T; Okano T; Sawa Y
Circulation; 2012 Sep; 126(11 Suppl 1):S29-37. PubMed ID: 22965990
[TBL] [Abstract][Full Text] [Related]
17. Phase I Clinical Trial of Autologous Stem Cell-Sheet Transplantation Therapy for Treating Cardiomyopathy.
Miyagawa S; Domae K; Yoshikawa Y; Fukushima S; Nakamura T; Saito A; Sakata Y; Hamada S; Toda K; Pak K; Takeuchi M; Sawa Y
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28381469
[TBL] [Abstract][Full Text] [Related]
18. Enhanced External Counterpulsation (EECP): An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(5):1-70. PubMed ID: 23074496
[TBL] [Abstract][Full Text] [Related]
19. Rationale and Design of a Clinical Trial to Evaluate the Safety and Efficacy of Intracoronary Infusion of Allogeneic Human Cardiac Stem Cells in Patients With Acute Myocardial Infarction and Left Ventricular Dysfunction: The Randomized Multicenter Double-Blind Controlled CAREMI Trial (Cardiac Stem Cells in Patients With Acute Myocardial Infarction).
Sanz-Ruiz R; Casado Plasencia A; Borlado LR; Fernández-Santos ME; Al-Daccak R; Claus P; Palacios I; Sádaba R; Charron D; Bogaert J; Mulet M; Yotti R; Gilaberte I; Bernad A; Bermejo J; Janssens S; Fernández-Avilés F
Circ Res; 2017 Jun; 121(1):71-80. PubMed ID: 28533209
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of direct cardiac shockwave therapy in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting (the CAST-HF trial): study protocol for a randomized controlled trial-an update.
Nägele F; Pölzl L; Graber M; Hirsch J; Mayr A; Pamminger M; Troger F; Theurl M; Schreinlechner M; Sappler N; Dorfmüller C; Mitrovic M; Ulmer H; Grimm M; Gollmann-Tepeköylü C; Holfeld J
Trials; 2022 Dec; 23(1):988. PubMed ID: 36494706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
